BritishHIVAssociation(BHIVA)guidelines forthetreatmentofHIV-infectedadultswithantiretroviraltherapyyTreatmentforadult HIVinfection:20066recommendationsoftheInternationalAIDSSociety-USA panelAntiretroviraldrugg resistancetestingginadultsinfectedwithhumanimmunodeficiencyyvirustype1: 20033recommendationsofanInternationalAIDSSociety-USAPanelReport2006:Priseenchargemédicaledes personnesinfectéesparleVIH,recommandationsdugrouped'expertsetal:Clinicallyyvalidatedgenotypeanalysis: guidinggprinciplesandstatisticalconcerns.AntivirTher2004, Comparisonoftestsandprocedurestoobuildclinicallyy relevantgenotypicscores:applicationtootheJaguarstudy.AntivirTher2005,ValderramaM:Usinggprincipalcomponentsforestimatingg logisticregressionwithhigh-dimensionalmulticollineardata.ComputStatDataa Anal2006,.. 9.. MassyW:PrincipalComponentsRegressioninExploratoryyStatisticalResearch. JournaloftheAmericannStatisticalAssociationn1965, pp.487-503827, 2006. ,
etal:Interpretationofgenotypeandpharmacokineticsfor resistancetoofosamprenavir-ritonavir-basedregimensinantiretroviralexperiencedpatients, pp.1473-1480, 2007. ,
Accurate prediction of HIV-1 drug response from the reverse transcriptase and protease amino acid sequences using sparse models created by convex optimization, Bioinformatics, vol.22, issue.5, pp.541-549 ,
DOI : 10.1093/bioinformatics/btk011
Mutationalpatternsand correlatedaminooacidsubstitutionsintheHIV-11proteaseaftervirologicalfailure toonelfinavir-andlopinavir/ritonavir-basedtreatments, pp.1617-1628 ,
etal:Emergenceofresistancetooproteaseinhibitor amprenavirinhumanimmunodeficiencyyvirustype1-infectedpatients:selection offouralternativeviralproteasegenotypesandinfluenceofviralsusceptibilityytoo coadministeredreversetranscriptasenucleosideinhibitors, AntimicrobbAgents Chemother2002, vol.46, pp.731-738 ,
LewinskiMA:IncreasinggprevalenceofHIV-11 proteaseinhibitor-associatedmutationscorrelateswithlong-termnonsuppressiveproteaseinhibitortreatment, pp.42-52, 2006. ,